Eribulin - PDFSEARCH.IO - Document Search Engine

Eribulin
Results: 22

#	Item
1	Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th Add to Reading List Source URL: apac-asia.com Language: English - Date: 2017-05-01 03:53:28
2	EISAI UND PIQUR UNTERZEICHNEN EINEN BAHNBRECHENDEN KOOPERATIONSVERTRAG ÜBER DIE UNTERSUCHUNG VON HALAVEN® (ERIBULIN) UND PQR309 BEI SCHWER BEHANDELBAREM BRUSTKREBS Der Vertrag sieht die Anwendung von Eribulin in Kombin Add to Reading List Source URL: www.piqur.com - Date: 2016-02-17 03:09:52
3	EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i Add to Reading List Source URL: www.piqur.com Language: English - Date: 2016-02-17 03:09:52 Clinical medicine Medicine Cancer Antineoplastic drugs Cancer treatments Signal transduction Breast cancer Macrolides Eribulin Halichondrin B MTOR inhibitors Eisai
4	Legend Open to Accrual Pending Accrual on Hold Advanced Breast Cancer Add to Reading List Source URL: cancer.ucsf.edu Language: English - Date: 2014-10-06 14:59:53 Breast cancer Metastatic breast cancer HER2/neu Biology Letrozole Eribulin Breast cancer treatment Breast cancer classification Medicine Oncology Ribbon symbolism
5	January 13, 2015 Eisai Co., Ltd. STATEMENT REGARDING NHS ENGLAND’S REASSESSMENT OF HALAVEN® FOR THE CANCER DRUGS FUND Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that, in Add to Reading List Source URL: www.eisai.com Language: English - Date: 2015-01-13 01:46:50 Eribulin Eisai Health Breast cancer National Health Service National Institute for Health and Clinical Excellence Medicine Ribbon symbolism Oncology
6	State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VTwww.dvha.vermont.gov Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2015-02-20 16:02:44 Ribbon symbolism Metastatic breast cancer Breast cancer Chemotherapy Medicaid Medicine Eribulin Cancer treatments
7	SCHEDULE OF PHARMACEUTICAL BENEFITS EFFICIENT FUNDING OF CHEMOTHERAPY – SECTION 100 ARRANGEMENTS SUPPLEMENT This schedule is also available on the internet at www.pbs.gov.au Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-02 00:13:48 Pharmaceuticals policy Pharmacology Pharmaceutical Benefits Scheme Oncology Chemotherapy Pharmacist Pharmacy Medical prescription Eribulin Medicine Health Healthcare in Australia
8	Microsoft Word[removed]Eribulin Eisai PSD March 13 final.docx Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-06 00:23:42 Organofluorides Eribulin Halichondrin B Ribbon symbolism Capecitabine Metastatic breast cancer Breast cancer Trastuzumab Eisai Medicine Pharmacology Drugs
9	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use See full prescribing HALAVEN® safely and effectively. information for HALAVEN. HALAVEN® (eribulin mesylate) Inject Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-08-04 14:23:47 Capecitabine Eribulin Methadone Flucytosine Norfloxacin Chemistry Organic chemistry Organofluorides
10	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Alkaloids Lactams Benzoates Bristol-Myers Squibb Diterpenes Eribulin Microtubule Paclitaxel Epothilone Biology Chemistry Cell biology

UPDATE